DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Azimilide is an investigational drug.
There have been 8 clinical trials for Azimilide. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2000.
The most common disease conditions in clinical trials are Atrial Fibrillation, Heart Diseases, and Emergencies. The leading clinical trial sponsors are Forest Laboratories, Warner Chilcott, and [disabled in preview].
Recent Clinical Trials for Azimilide
|Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)||Forest Laboratories||Phase 3|
|Effect of Azimilide Dihydrochloride on Renal Function||Warner Chilcott||Phase 1|
|Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient||Warner Chilcott||Phase 2|